SILVERARC CAPITAL MANAGEMENT LLC 13D and 13G filings for Benitec Biopharma Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-07 5:38 pm Sale |
2022-12-31 | 13G | Benitec Biopharma Inc. BNTC |
SILVERARC CAPITAL MANAGEMENT LLC | 0 0.000% |
-34,559 (Position Closed) |
Filing |
| 2022-02-10 09:09 am Unchanged |
2021-12-31 | 13G | Benitec Biopharma Inc. BNTC |
SILVERARC CAPITAL MANAGEMENT LLC | 34,559 7.200% |
0 (Unchanged) |
Filing |
| 2022-02-10 09:07 am Unchanged |
2021-12-31 | 13G | Benitec Biopharma Inc. BNTC |
SILVERARC CAPITAL MANAGEMENT LLC | 34,559 7.200% |
0 (Unchanged) |
Filing |
| 2022-02-09 4:39 pm Purchase |
2021-12-31 | 13G | Benitec Biopharma Inc. BNTC |
SILVERARC CAPITAL MANAGEMENT LLC | 34,559 7.200% |
34,559 (New Position) |
Filing |